DOI: 10.12890/2022_003475

Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection

Authors

  • Islam Meijri Pneumology Department, Military Hospital, Tunis, Tunisia
  • Nouha Boubaker Pneumology Department, Military Hospital, Tunis, Tunisia
  • Tasnim Znegui Pneumology Department, Military Hospital, Tunis, Tunisia
  • Selsabil Daboussi Pneumology Department, Military Hospital, Tunis, Tunisia
  • Chiraz Aichaouia Pneumology Department, Military Hospital, Tunis, Tunisia
  • Samira Mhamdi Pneumology Department, Military Hospital, Tunis, Tunisia
  • Zied Moatemri Pneumology Department, Military Hospital, Tunis, Tunisia

zneguitasnim@gmail.com

Keywords

COVID-19, haemoptysis, embolisation

Abstract

Background: Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations.

Case description: We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successful management using endovascular embolization.

Discussion: Life-threatening massive haemoptysis has rarely been reported as the only manifestation of COVID-19. Embolisation was the therapeutic option chosen to manage this emergency. 

View the entire article

Downloads

References

  1. Peys E, Stevens D, Weygaerde YV, Malfait T, Hermie L, Rogiers P, et al. Haemoptysis as the first presentation of COVID-19: a case report. BMC Pulm Med 2020;20(1):275.
  2. Yu C, Lei Q, Li W, Wang X, Li W, Liu W. Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience. J Infect Public Health 2020;13(9):1202–1209.
  3. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect 2020;53(3):404–412.
  4. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623.
  5. Argun Baris S, Coskun IS, Selvi G, Boyaci H, BasyigitI. Case series of COVID-19 presenting with massive hemoptysis. Turk Thorac J 2020;21(6):454–456.
  6. Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features. Korean J Radiol 2020;21(5):537.
  7. Jajodia S, Goenka U, Jash D, Tiwary I, Goenka MK. Endovascular management of massive hemoptysis due to COVID-19 related pulmonary artery pseudoaneurysm: a rare entity. Radiol Case Rep 2021;16(11):3597–3601.
  8. Rott G, Boecker F, Maurer C, Sellmann T. Massive hemoptysis two months after an otherwise mild SARS-CoV-2 disease (COVID-19) treated with bronchial artery embolization - a case report. Radiol Case Rep 2022;17(3):918–921.
  9. Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020;77(2):198–209.
  10. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 2020;41(19):1858–1858.
  11. Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med 2020;38(7):1544.e1–1544.e3.

Published

2022-08-01

How to Cite

1.
Meijri I, Boubaker N, Znegui T, Daboussi S, Aichaouia C, Mhamdi S, et al. Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection. EJCRIM [Internet]. 2022 Aug. 1 [cited 2026 Nov. 3];9(8). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3475

Most read articles by the same author(s)